Perturbation of hypothalamic microrna expression patterns in male rats after metabolic distress: Impact of obesity and conditions of negative energy balance

Endocrinology

Volumn 155, Issue 5, 2014, Pages 1838-1850

  Sangiao Alvarellos, Susana ^a,b   Pena Bello, Lara ^a,b,c   Manfredi Lozano, María ^d   Tena Sempere, Manuel ^d   Cordido, Fernando ^a,b,c  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b Instituto de Investigacion Biomedica de A Coruna   (Spain)

^c HOSPITAL JUAN CANALEJO   (Spain)

^d UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN; MICRORNA; MICRORNA 132; MICRORNA 145; MICRORNA 200A; MICRORNA 9; MIR 218; MIR 30E; MIR LET 7A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; ENERGY BALANCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIGH THROUGHPUT SCREENING; HYPOTHALAMUS; INFLAMMATION; LIPID DIET; MALE; METABOLIC STRESS; NONHUMAN; NUTRITIONAL ASSESSMENT; OBESITY; PRIORITY JOURNAL; RAT; RNA ANALYSIS; RNA METABOLISM;

AGING; ANIMALS; APPETITE DEPRESSANTS; BODY COMPOSITION; CALORIC RESTRICTION; COMPUTATIONAL BIOLOGY; DIET, HIGH-FAT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPOTHALAMUS; LEPTIN; MALE; MALNUTRITION; MICRORNAS; MODELS, BIOLOGICAL; NEURONS; OBESITY; RATS; RATS, WISTAR; WEANING;

EID: 84899459495     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1770     Document Type: Article

References (72)

1. WorldHealth Organization. Diabetes fact sheet no.312. Geneva, Switzerland: World Health Organization; 2013. http://www.who.int/mediacentre/ factsheets/fs312/en/. Accessed February 21, 2014
2. Travers ME, McCarthy MI. Type 2 diabetes and obesity: genomics and the clinic. Hum Genet. 2011;130:41-58
3. Remmers F, Delemarre-van de Waal HA. Developmental programming of energy balance and its hypothalamic regulation. Endocr Rev. 2011;32:272-311
4. Bouret SG, Simerly RB. Developmental programming of hypothalamic feeding circuits. Clin Genet. 2006;70:295-301 (Pubitemid 44323392)
5. Williams LM. Hypothalamic dysfunction in obesity. Proc Nutr Soc. 2012;71:521-533
6. Cai D. Neuroinflammation and neurodegeneration in overnutrition- induced diseases. Trends Endocrinol Metab. 2013;24:40-47
7. Thaler JP, Yi CX, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012;122: 153-162
8. Ahima RS, Lazar MA. Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol. 2008;22:1023-1031 (Pubitemid 351629604)
9. Ahima RS, Qi Y, Singhal NS, Jackson MB, Scherer PE. Brain adipocytokine action and metabolic regulation. Diabetes. 2006;55(suppl 2): S145-S154 (Pubitemid 44927045)
10. Chen HC, Roth JD, Schroeder BE, Weyer C. Role of islet-, gut-, and adipocyte-derived hormones in the central control of food intake and body weight: implications for an integrated neurohormonal approach to obesity pharmacotherapy. Curr Diabetes Rev. 2008; 4:79-91
11. Belgardt BF, Brüning JC. CNS leptin and insulin action in the control of energy homeostasis. Ann NY Acad Sci. 2010;1212:97-113
12. Carvalheira JB, Torsoni MA, Ueno M, et al. Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. Obes Res. 2005;13:48-57
13. Bjørbaek C. Central leptin receptor action and resistance in obesity. J Investig Med. 2009;57:789-794
14. van den Hoek AM, Teusink B, Voshol PJ, Havekes LM, Romijn JA, Pijl H. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice. J Neuroendocrinol. 2008;20:120-127 (Pubitemid 350239156)
15. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387:903-908 (Pubitemid 27289591)
16. Hedbacker K, Birsoy K, Wysocki RW, et al. Antidiabetic effects of IGFBP2, a leptin-regulated gene. Cell Metab. 2010;11:11-22
17. Dridi S, Taouis M. Adiponectin and energy homeostasis: consensus and controversy. J Nutr Biochem. 2009;20:831-839
18. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature. 2008;455:64-71
19. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27:91-105 (Pubitemid 46991392)
20. Zhao S, Liu MF. Mechanisms of microRNA-mediated gene regulation. Sci China C Life Sci. 2009;52:1111-1116
21. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11:441- 450 (Pubitemid 44430905)
22. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003;9:1274-1281 (Pubitemid 37151681)
23. Alexander R, Lodish H, Sun L. MicroRNAs in adipogenesis and as therapeutic targets for obesity. Expert Opin Ther Targets. 2011; 15:623-636
24. Frost RJ, Olson EN. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc Natl Acad Sci USA. 2011;108:21075-21080
25. Heneghan HM, Miller N, Kerin MJ. Role of microRNAs in obesity and the metabolic syndrome. Obes Rev. 2010;11:354-361
26. Bolmeson C, Esguerra JL, Salehi A, Speidel D, Eliasson L, Cilio CM. Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects. Biochem Biophys Res Commun. 2011;404: 16-22
27. PoyMN,Hausser J, Trajkovski M, et al. miR-375 maintains normal pancreatic α- and β-cell mass. Proc Natl Acad Sci USA. 2009;106: 5813-5818
28. Trajkovski M, Hausser J, Soutschek J, et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature. 2011;474:649-653
29. Takanabe R, Ono K, Abe Y, et al. Up-regulated expression of microRNA- 143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun. 2008;376:728-732
30. Jordan SD, Krüger M, Willmes DM, et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol. 2011;13:434-446
31. Zhu H, Shyh-Chang N, Segrè AV, et al. The Lin28/let-7 axis regulates glucose metabolism. Cell. 2011;147:81-94
32. Sangiao-Alvarellos S, Manfredi-Lozano M, Ruiz-Pino F, et al. Changes in hypothalamic expression of the Lin28/let-7 system and related microRNAs during postnatal maturation and after experimental manipulations of puberty. Endocrinology. 2013;154:942- 955
33. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11: 597-610
34. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell. 2003;115:787-798 (Pubitemid 38058492)
35. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol. 2004;2:e363
36. Krek A, Grün D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37:495-500 (Pubitemid 40617277)
37. Maragkakis M, Reczko M, Simossis VA, et al. DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 2009;37:W273-W276
38. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk - database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 2011;44:839-847
39. Chang GQ, Gaysinskaya V, Karatayev O, Leibowitz SF. Maternal high-fat diet and fetal programming: increased proliferation of hypothalamic peptide-producing neurons that increase risk for overeating and obesity. J Neurosci. 2008;28:12107-12119
40. Page KC, Malik RE, Ripple JA, Anday EK. Maternal and postweaning diet interaction alters hypothalamic gene expression and modulates response to a high-fat diet in male offspring. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1049-R1057
41. Yamashima T. 'PUFA-GPR40-CREB signaling' hypothesis for the adult primate neurogenesis. Prog Lipid Res. 2012;51:221-231
42. Barco A, Marie H. Genetic approaches to investigate the role of CREB in neuronal plasticity and memory. Mol Neurobiol. 2011; 44:330-349
43. Poy MN, Spranger M, Stoffel M. microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab. 2007;9(suppl 2): 67-73 (Pubitemid 47543128)
44. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Transl Res. 2011;157:253-264
45. McGregor RA, Choi MS. microRNAs in the regulation of adipogenesis and obesity. Curr Mol Med. 2011;11:304-316
46. Sacco J, Adeli K. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Curr Opin Lipidol. 2012;23:220-225
47. Amar L, Benoit C, Beaumont G, et al. MicroRNA expression profiling of hypothalamic arcuate and paraventricular nuclei from single rats using Illumina sequencing technology. J Neurosci Methods. 2012;209:134-143
48. Herzer S, Silahtaroglu A, Meister B. Locked nucleic acid-based in situ hybridisation reveals miR-7a as a hypothalamus-enriched microRNA with a distinct expression pattern. J Neuroendocrinol. 2012;24:1492-1504
49. Uesugi A, Kozaki K, Tsuruta T, et al. The tumor suppressive microRNA miR-218 targets themTORcomponent Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res. 2011;71:5765- 5778
50. Venkataraman S, Birks DK, Balakrishnan I, et al. MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotypeassociated genes in medulloblastoma. J Biol Chem. 2013;288: 1918-1928
51. Benoit C, Ould-Hamouda H, Crepin D, et al. Early leptin blockade predisposes fat-fed rats to overweight and modifies hypothalamic microRNAs. J Endocrinol. 2013;218:35-47
52. Coolen M, Thieffry D, Drivenes Ø, Becker TS, Bally-Cuif L. miR-9 controls the timing of neurogenesis through the direct inhibition of antagonistic factors. Dev Cell. 2012;22:1052-1064
53. Kawahara H, Imai T,OkanoH.MicroRNAsin neural stem cells and neurogenesis. Front Neurosci. 2012;6:30
54. Pathania M, Torres-Reveron J, Yan L, et al. A miR-132 enhances dendritic morphogenesis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons. PLoS One. 2012;7: e38174
55. Yoo AS, Sun AX, Li L, et al. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature. 2011;476:228-231
56. Nigro A, Menon R, Bergamaschi A, et al. MiR-30e and miR-181d control radial glia cell proliferation via HtrA1 modulation. Cell Death Dis. 2012;3:e360
57. Liu C, Zhao X. MicroRNAs in adult and embryonic neurogenesis. Neuromolecular Med. 2009;11:141-152
58. Lang MF, Shi Y. Dynamic roles of microRNAs in neurogenesis. Front Neurosci. 2012;6:71
59. Choi PS, Zakhary L, Choi WY, et al. Members of the miRNA-200 family regulate olfactory neurogenesis. Neuron. 2008;57:41-55
60. Milanski M, Arruda AP, Coope A, et al. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes. 2012;61:1455-1462
61. Zhang X, Zhang G, Zhang H, KarinM,Bai H, Cai D. Hypothalamic IKKβ/NF-B and ER stress link overnutrition to energy imbalance and obesity. Cell. 2008;135:61-73
62. Koch L, Wunderlich FT, Seibler J, et al. Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest. 2008;118:2132-2147 (Pubitemid 351872332)
63. Buettner C, Muse ED, Cheng A, et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med. 2008;14:667-675 (Pubitemid 351809549)
64. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci. 2002;5:566-572 (Pubitemid 34568999)
65. Ring LE, Zeltser LM. Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels. J Clin Invest. 2010;120: 2931-2941
66. Clegg DJ, Gotoh K, Kemp C, et al. Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiol Behav. 2011;103:10-16
67. Caricilli AM, Penteado E, de Abreu LL, et al. Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice. Endocrinology. 2012;153:4401-4411
68. Bjørbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem. 1999;274: 30059-30065
69. de Backer MW, Brans MA, van Rozen AJ, et al. Suppressor of cytokine signaling 3 knockdown in the mediobasal hypothalamus: counterintuitive effects on energy balance. J Mol Endocrinol. 2010; 45:341-353
70. Song L,HuangQ, Chen K, et al. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun. 2010;402:135-140
71. Xia H, Yan Y, Hu M, et al. MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-B activity. Neuro Oncol. 2013;15:413-422
72. Shaked I, Meerson A, Wolf Y, et al. MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity. 2009;31:965-973. Raras